April 26, 2017

PA Waiver Training Module

John J. Mariani, MD

Begin Course

Educational Objectives:

  • Describe the regulatory oversight for opioid agonist replacement treatment
  • State the guidelines for documentation and informed consent procedures when providing opioid use disorder (OUD) medication-assisted treatment (MAT)
  • Identify how to determine the adequate level of psychosocial treatment and frequency of pharmacotherapy visits when providing MAT
  • Implement documentation and administrative practices into care of patients receiving OUD MAT